Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘ori investigations’ Category

US court denies virus researcher’s latest appeal challenging 7-year funding ban

without comments

Scott Brodie has almost run out of options.

A former professor at the University of Washington, Brodie is currently involved in his third lawsuit challenging a finding of scientific misconduct and a seven-year funding ban handed down in 2010 by the U.S. Department of Health and Human Services’ Office of Research Integrity. He says that in the time since his case was heard by an administrative law judge at the ORI level, new evidence has come to light that shows he “did not have a ‘full and fair opportunity to litigate’ the issues.” His lawsuit sought a court order to have the ORI revisit its decision.

Last year, a U.S. District Court judge dismissed the case, saying it revisited old issues that had already been litigated, but Brodie appealed that decision. Now, his quest may have come to an end: On Nov. 27, the U.S. Court of Appeals for the D.C. Circuit dismissed the appeal. If he wants to continue the case, Brodie’s only remaining option is to appeal the decision to the U.S. Supreme Court.

In the court order, the panel of three judges wrote:

Read the rest of this entry »

Written by Andrew P. Han

December 8th, 2017 at 11:00 am

Director of U.S. HHS Office of Research Integrity temporarily removed from post

with 17 comments

Kathy Partin

After a tumultuous two years, Kathy Partin is temporarily stepping away from her position as the director of the U.S. Office of Research Integrity.

According to an internal personnel announcement forwarded to us, on December 4, Partin will begin a 90-day stint at the Office of the Vice President for Research at the Uniformed Services University of the Health Sciences, which trains health professionals to support the U.S. military.

Partin declined to comment. A spokesperson for the Department of Health and Human Services (HHS), of which the Office of Research Integrity is a part, told us the agency cannot comment on personnel issues.

Linda Schutjer, a former colleague of Partin’s at Colorado State University, told us Partin was asked to leave:

Read the rest of this entry »

Written by Alison McCook

November 20th, 2017 at 11:49 am

Caught Our Notice: Another retraction for researcher paid $100k to leave uni

without comments

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, just shy of 1,000 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at

Title:  Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway  and  Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway 

What caught our attention:

Read the rest of this entry »

Division director leaving U.S. research watchdog after nearly 15 years

with 7 comments

Susan Garfinkel

The director of the Division of Investigative Oversight at the U.S. Office of Research Integrity is leaving the agency.

Susan Garfinkel told Retraction Watch that her last day is November 10. She is taking a position as assistant vice president in the Office of Research Compliance at The Ohio State University (OSU).

Garfinkel declined to comment on why she was leaving the agency:

Read the rest of this entry »

Written by Alison McCook

October 16th, 2017 at 11:37 am

ORI finds misconduct in case of biologist paid $100K by university to leave

with 8 comments

A biologist who studied the impact of diabetes on the eye inappropriately altered data in five images from three papers, according to a new finding of misconduct issued by the U.S. Office of Research Integrity (ORI).

Readers may be familiar with the subject of the findings: Azza El-Remessy, a former tenured associate professor at the University of Georgia (UGA) in Athens, spoke to us earlier this year about her battle with UGA. In June 2016, UGA found her guilty of research misconduct and recommended she be terminated. El-Remessy fought back, hiring a lawyer to contest the findings, and the university ultimately paid her $100,000 to leave. (For more, here’s UGA’s June 2016 investigation report and the settlement agreement between UGA and El-Remessy.) Read the rest of this entry »

Written by Victoria Stern

October 2nd, 2017 at 11:05 am

Recent finding of misconduct by federal U.S. agency sparks debate

with 18 comments

Nasser Chegini

In 2011, the University of Florida assembled a misconduct report about one of its ob-gyn researchers, identifying falsified data in a 2010 paper. But when an investigator at the U.S. Office of Research Integrity reviewed the report, something didn’t feel right.

“I reviewed the data, and I thought [UF] didn’t do their due diligence,” said Kristen Grace, then an ORI investigator, now heading up the compliance department of the Office of Clinical Research at the University of Pennsylvania. “Because the extent of the the falsification was so great.”

So the ORI asked the UF to re-open its investigation, expanding it to include previous years of work by Nasser Chegini, now retired. The institution also hired a new director of research compliance, who oversaw the second investigation. That report, completed in October 2013, was significantly more extensive — it documented intentional falsifications or fabrications in nine papers published between 2003-2008. (Through a public records request, we obtained a copy of this second report, which you can read in full here.) But last month, the ORI issued a finding of misconduct against Chegini that focused on only one paper; the agency said it chose to take a “targeted approach,” since eight of the nine papers had already been retracted.  

The move has prompted a debate — while some argue it’s a pragmatic use of ORI’s limited resources, others (including Grace) are concerned:

Read the rest of this entry »

Written by Alison McCook

August 17th, 2017 at 11:13 am

After investigation that started at least 5 years ago, retired ob-gyn prof agrees to 5 years of supervision

with 8 comments

Nasser Chegini

A now-retired professor tweaked the findings in seven figures of a 2007 paper, according to a new finding of misconduct released yesterday by the U.S. Office of Research Integrity.

The subject of the findings isn’t a stranger to our readers: We’ve already reported on nine retractions for Nasser Chegini, a former professor of obstetrics and gynecology at the University of Florida (UF) who had won more than $4 million in Federal grants. And Chegini, who retired in early 2012, had been under investigation since at least 2012, with the ORI asking UF to broaden that investigation at one point.

Indeed, the ORI’s notice states that eight of Chegini’s retractions resulted from the UF’s investigation. The ORI’s findings, however, stem from another paper, published in the Journal of Reproductive Immunology, which has not been retracted.

According to the ORI, in that paper, Chegini:

Read the rest of this entry »

Why did it take a journal two years to retract a paper after a misconduct finding?

with one comment

A 2014 paper containing data manipulated by a former graduate student has finally been retracted, two years after the U.S. Office of Research Integrity (ORI) published its findings.

In August 2015, the ORI published a report that Peter Littlefield, who was working on his PhD at the University of California, San Francisco (UCSF), had committed “research misconduct by falsifying and/or fabricating data” in two papers. Littlefield agreed to correct or retract the papers–one published in Chemistry & Biology and the other in Science Signaling.  

When we contacted Chemistry & Biology back in August 2015, a spokesperson for Cell Press told us the journal was figuring out “the best way to correct the scientific record.”

Apparently that took two years. In the meantime, the journal did not issue an expression of concern or otherwise notify readers of the issues. Read the rest of this entry »

PLOS ONE retracts paper after researcher admits to fabricating data

with 2 comments

On June 19, 2017, the U.S. Office of Research Integrity published its first misconduct finding of the year. The ORI reported that Brandi M. Baughman — a former research training awardee at the National Institute of Environmental and Health Sciences (NIEHS) — had “falsified and/or fabricated data” in 11 figures in a 2016 paper published in PLOS ONE.

Two days later, on June 21, PLOS ONE retracted the paper. (Note: The retraction process proceeded relatively quickly, but took longer than two days; a spokesperson for the journal told us that the authors alerted the editors of their concerns about the publication in May.)   Read the rest of this entry »

Written by Victoria Stern

July 26th, 2017 at 8:00 am

Ex-Wayne State scientist, ORI square off in court

with 12 comments

WASHINGTON, D.C — Last week, former brain scientist Christian Kreipke stared down the third set of research misconduct allegations against him since 2011. Or, possibly, according to him, it was the third iteration of the same research misconduct allegations he’s faced for years, a piling on by the most powerful of the three institutions out to ruin him after he allegedly uncovered a grant fraud scheme at Wayne State University, his former employer.

All the same, over three days Kreipke faced off against the U.S. Office of Research Integrity in a virtual administrative law courtroom as he contested a finding of research misconduct and an accompanying 10-year ban on receiving federal funding. In Washington, prosecutor Patricia Mantoan, a U.S. Department of Health and Human Services (HHS) attorney representing the ORI, brought the government’s case against him, wrapping up well before the end of Monday, July 10. Onlookers at the public hearing watched on video monitors as Kriepke sweated, literally, through hours of testimony, much of it with him on the witness stand. Despite being confined to what his lawyer, Shereef Akeel, of Detroit-area firm Akeel & Valentine called an “85 degree” room at the U.S. District Court in Detroit, Kreipke’s defense team took their time laying out his side of the story.

Since the allegations were first raised, Kreipke’s defense has remained largely the same: the misconduct allegations from Wayne State, brought in 2011, are retaliation against him for raising doubts the year before about accounting practices related to federal grants. At trial, Akeel characterized Wayne State’s misconduct investigation as a “witch hunt” that was out to get Kreipke, no matter what. Read the rest of this entry »

Written by Andrew P. Han

July 18th, 2017 at 8:00 am